Supplement |
Changing patterns and trends in systemic fungal infections
1 Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland; 2 Laboratory Diagnostics, Helsinki University Central Hospital, Helsinki, Finland
* Tel: +358-9-191-26894; Fax: +358-9-191-26382; E-mail: Malcolm.Richardson{at}helsinki.fi
Invasive mycoses are a significant and growing public health problem. Although bloodstream infections with Candida albicans may be decreasing in frequency, the number of persons at risk for them continues to grow. Moreover, infections with other Candida species, such as Candida glabrata, are increasing in incidence. Invasive mould infections in general, and Aspergillus infections in particular, are becoming more frequent. Fungal opportunistic infections in persons with AIDS are no longer a major problem in developed countries, but are resulting in significant morbidity and mortality in developing countries with AIDS epidemics. Further studies are needed to define populations at very high risk for fungal opportunistic infections who might benefit from targeted antifungal chemoprophylaxis, which remains the most promising of the potential prevention strategies. This review highlights the changing patterns in risk factors, changes in epidemiology, the impact of changes in medical practice in intensive care and organ transplantation on the incidence of systemic fungal infections, and gives an overview of fungal infections in paediatric patients, patients with haematological malignancy, and the emergence of antifungal resistance.
Keywords: aspergillosis , candidosis , antifungals
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. J. Seneviratne, L. J. Jin, Y. H. Samaranayake, and L. P. Samaranayake Cell Density and Cell Aging as Factors Modulating Antifungal Resistance of Candida albicans Biofilms Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3259 - 3266. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Burgos, T. E. Zaoutis, C. C. Dvorak, J. A. Hoffman, K. M. Knapp, J. J. Nania, P. Prasad, and W. J. Steinbach Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases Pediatrics, May 1, 2008; 121(5): e1286 - e1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. S. H. Mennink-Kersten, D. Ruegebrink, R. R. Klont, A. Warris, N. M. A. Blijlevens, J. P. Donnelly, and P. E. Verweij Improved Detection of Circulating Aspergillus Antigen by Use of a Modified Pretreatment Procedure J. Clin. Microbiol., April 1, 2008; 46(4): 1391 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Chung, H. K. Lim, J.-C. Kim, G. J. Choi, E. J. Park, M. H. Lee, Y. R. Chung, and S.-W. Lee Forest Soil Metagenome Gene Cluster Involved in Antifungal Activity Expression in Escherichia coli Appl. Envir. Microbiol., February 1, 2008; 74(3): 723 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
Generalized Papules in a Patient With Acute Myeloid Leukemia Diagnosis Arch Dermatol, December 1, 2007; 143(12): 1583 - 1588. [Full Text] [PDF] |
||||
![]() |
K. Gulshan and W. S. Moye-Rowley Multidrug Resistance in Fungi Eukaryot. Cell, November 1, 2007; 6(11): 1933 - 1942. [Full Text] [PDF] |
||||
![]() |
C. Gregori, C. Schuller, A. Roetzer, T. Schwarzmuller, G. Ammerer, and K. Kuchler The High-Osmolarity Glycerol Response Pathway in the Human Fungal Pathogen Candida glabrata Strain ATCC 2001 Lacks a Signaling Branch That Operates in Baker's Yeast Eukaryot. Cell, September 1, 2007; 6(9): 1635 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ueno, J. Uno, H. Nakayama, K. Sasamoto, Y. Mikami, and H. Chibana Development of a Highly Efficient Gene Targeting System Induced by Transient Repression of YKU80 Expression in Candida glabrata Eukaryot. Cell, July 1, 2007; 6(7): 1239 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Yadav, R. Mandhan, Q. Pasha, S. Pasha, A. Katyal, A. K. Chhillar, J. Gupta, R. Dabur, and G. L. Sharma An antifungal protein from Escherichia coli J. Med. Microbiol., May 1, 2007; 56(5): 637 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sendid, N. Francois, A. Standaert, E. Dehecq, F. Zerimech, D. Camus, and D. Poulain Prospective evaluation of the new chromogenic medium CandiSelect 4 for differentiation and presumptive identification of the major pathogenic Candida species J. Med. Microbiol., April 1, 2007; 56(4): 495 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Soloviev, W. A. Fonzi, R. Sentandreu, E. Pluskota, C. B. Forsyth, S. Yadav, and E. F. Plow Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin {alpha}Mbeta2 J. Immunol., February 15, 2007; 178(4): 2038 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Arnaud, M. C. Costanzo, M. S. Skrzypek, P. Shah, G. Binkley, C. Lane, S. R. Miyasato, and G. Sherlock Sequence resources at the Candida Genome Database Nucleic Acids Res., January 12, 2007; 35(suppl_1): D452 - D456. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Isham and M. A. Ghannoum Determination of MICs of Aminocandin for Candida spp. and Filamentous Fungi J. Clin. Microbiol., December 1, 2006; 44(12): 4342 - 4344. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Brown, J. A. Sexton, and M. Johnston A Glucose Sensor in Candida albicans. Eukaryot. Cell, October 1, 2006; 5(10): 1726 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lincopan and A. M. Carmona-Ribeiro Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole J. Antimicrob. Chemother., July 1, 2006; 58(1): 66 - 75. [Abstract] [Full Text] [PDF] |
||||









